Published in Cancer on November 01, 1999
Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor-beta signaling. Am J Respir Cell Mol Biol (2007) 1.78
Lung cancer patients' CD4(+) T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells. Cancer Immunol Immunother (2008) 1.45
Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition. Mol Cancer Ther (2010) 1.30
TGF-β-induced IRAK-M expression in tumor-associated macrophages regulates lung tumor growth. Oncogene (2011) 1.15
Targeting miR-23a in CD8+ cytotoxic T lymphocytes prevents tumor-dependent immunosuppression. J Clin Invest (2014) 1.11
Treatment for radiation-induced pulmonary late effects: spoiled for choice or looking in the wrong direction? Curr Drug Targets (2010) 1.03
Cytokine plasma levels: reliable predictors for radiation pneumonitis? PLoS One (2008) 1.02
Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk. Prostate (2010) 1.02
Early alterations in cytokine expression in adult compared to developing lung in mice after radiation exposure. Radiat Res (2010) 1.01
Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res (2016) 0.99
Active-specific immunotherapy for non-small cell lung cancer. J Thorac Dis (2011) 0.99
Influence of TGFB1+869T>C functional polymorphism in non-small cell lung cancer (NSCLC) risk. J Cancer Res Clin Oncol (2010) 0.89
Targeting the immune system in non-small-cell lung cancer: bridging the gap between promising concept and therapeutic reality. Clin Lung Cancer (2010) 0.88
Locally advanced lung cancer: an optimal setting for vaccines and other immunotherapies. Cancer J (2013) 0.82
Lung cancer vaccines. Cancer J (2011) 0.82
Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancer. Physiol Genomics (2014) 0.82
Regulation of complement-dependent cytotoxicity by TGF-β-induced epithelial-mesenchymal transition. Oncogene (2015) 0.82
Differential knockdown of TGF-β ligands in a three-dimensional co-culture tumor- stromal interaction model of lung cancer. BMC Cancer (2014) 0.81
Actual status of therapeutic vaccination in non-small cell lung cancer. Contemp Oncol (Pozn) (2014) 0.80
TGFβ1 Polymorphisms Predict Distant Metastasis-Free Survival in Patients with Inoperable Non-Small-Cell Lung Cancer after Definitive Radiotherapy. PLoS One (2013) 0.78
Inhibition of TGF-β signaling with halofuginone can enhance the antitumor effect of irradiation in Lewis lung cancer. Onco Targets Ther (2015) 0.78
Therapeutic cancer vaccines: the latest advancement in targeted therapy. Am J Ther (2012) 0.78
A phase I dose-escalation study to a predefined dose of a transforming growth factor-β1 monoclonal antibody (TβM1) in patients with metastatic cancer. Int J Oncol (2014) 0.77
High tumor-associated macrophages infiltration is associated with poor prognosis and may contribute to the phenomenon of epithelial-mesenchymal transition in gastric cancer. Onco Targets Ther (2016) 0.77
TGF-β Suppresses COX-2 Expression by Tristetraprolin-Mediated RNA Destabilization in A549 Human Lung Cancer Cells. Cancer Res Treat (2014) 0.76
Circulating immunoglobulin-bound transforming growth factor beta at a late tumour-bearing stage impairs antigen-specific responses of CD4+ T cells. Clin Exp Immunol (2002) 0.76
Therapeutic vaccines in non-small cell lung cancer. Immunotargets Ther (2013) 0.75
Targeted immunotherapy for non-small cell lung cancer. World J Clin Oncol (2014) 0.75
Transforming growth factor-β1 rs1800470 polymorphism is associated with lung cancer risk: a meta-analysis. Med Sci Monit (2014) 0.75
Preoperative administration of polysaccharide Kureha and reduced plasma transforming growth factor-β in patients with advanced gastric cancer: A randomized clinical trial. Mol Clin Oncol (2015) 0.75
Pulmonary toxicity generated from radiotherapeutic treatment of thoracic malignancies. Oncol Lett (2017) 0.75
INDOL AND SKATOL DETERMINATION IN BACTERIAL CULTURES. J Bacteriol (1925) 16.44
Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology. Peptides (1986) 3.51
Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys (1995) 3.20
The trithorax gene, a trans-acting regulator of the bithorax complex in Drosophila, encodes a protein with zinc-binding domains. Proc Natl Acad Sci U S A (1990) 2.85
Novel imprinted DLK1/GTL2 domain on human chromosome 14 contains motifs that mimic those implicated in IGF2/H19 regulation. Genome Res (2000) 2.73
Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys (2001) 2.71
Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys (2001) 2.59
The measured electrical properties of normal and malignant human tissues from 50 to 900 MHz. Med Phys (1994) 2.32
Genomic imprinting: implications for human disease. Am J Pathol (1999) 2.26
Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Radiother Oncol (1999) 2.25
Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas. Ann Surg Oncol (2001) 2.01
Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg (1995) 1.90
Liver regeneration studies with rat hepatocytes in primary culture. Cancer Res (1982) 1.81
M6P/IGF2R imprinting evolution in mammals. Mol Cell (2000) 1.77
M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet (1995) 1.77
Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys (1998) 1.65
The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys (1995) 1.58
Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med (1993) 1.45
Radiation-induced hypoxia may perpetuate late normal tissue injury. Int J Radiat Oncol Biol Phys (2001) 1.42
Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor. Ann Surg (1995) 1.40
Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation. Endocrinology (1995) 1.38
Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta. Int J Radiat Oncol Biol Phys (2001) 1.38
Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience. Int J Radiat Oncol Biol Phys (1998) 1.36
Divergent evolution in M6P/IGF2R imprinting from the Jurassic to the Quaternary. Hum Mol Genet (2001) 1.32
M6P/IGF2 receptor: a candidate breast tumor suppressor gene. Oncogene (1996) 1.31
Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis. Proc Natl Acad Sci U S A (1997) 1.29
Monotreme IGF2 expression and ancestral origin of genomic imprinting. J Exp Zool (2001) 1.28
Transforming growth factor-beta 1 expression in irradiated liver. Radiat Res (1990) 1.27
The neuronatin gene resides in a "micro-imprinted" domain on human chromosome 20q11.2. Genomics (2001) 1.24
Transplantation system for determining the clonogenic survival of parenchymal hepatocytes exposed to ionizing radiation. Cancer Res (1981) 1.22
Imprinted genes in liver carcinogenesis. FASEB J (1997) 1.22
Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors. Oncogene (1995) 1.22
Bacterial infection promotes DNA hypermethylation. J Dent Res (2007) 1.22
Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor (M6P/IGF2R) locus predisposes patients to radiation-induced lung injury. Int J Radiat Oncol Biol Phys (2001) 1.21
Functional reconstruction of trans regulation of the Ultrabithorax promoter by the products of two antagonistic genes, trithorax and Polycomb. Mol Cell Biol (1995) 1.21
Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis. Int J Radiat Oncol Biol Phys (1997) 1.20
The physical parameters and molecular events associated with radiation-induced lung toxicity. Semin Radiat Oncol (2000) 1.20
Clinical and dosimetric predictors of radiation-induced esophageal toxicity. Int J Radiat Oncol Biol Phys (1999) 1.19
Changes in plasma TGF beta levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis. Int J Radiat Oncol Biol Phys (1994) 1.19
Theoretical and measured electric field distributions within an annular phased array: consideration of source antennas. IEEE Trans Biomed Eng (1993) 1.17
A simple approach to prenatal diagnosis of beta-thalassemia in a geographic area where multiple mutations occur. Blood (1988) 1.17
Transforming growth factor-beta 1 as a signal for induction of cell death by apoptosis. Br J Cancer (1993) 1.16
Epigenetic detection of human chromosome 14 uniparental disomy. Hum Mutat (2003) 1.15
Neoadjuvant chemoradiation for rectal cancer: analysis of clinical outcomes from a 13-year institutional experience. Ann Surg (2001) 1.15
M6P/IGF2R is mutated in squamous cell carcinoma of the lung. Oncogene (2000) 1.14
Isolation, culture, and transplantation of human hepatocytes. J Natl Cancer Inst (1982) 1.12
Essential role of Drosophila Hdac1 in homeotic gene silencing. Proc Natl Acad Sci U S A (2001) 1.10
Marsupials and Eutherians reunited: genetic evidence for the Theria hypothesis of mammalian evolution. Mamm Genome (2001) 1.09
More about prostate cancer--expectant management versus treatment. N C Med J (1999) 1.08
Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects. Lung Cancer (1999) 1.06
Hypoxia inducible factor 1alpha signaling in fractionated radiation-induced lung injury: role of oxidative stress and tissue hypoxia. Radiat Res (2010) 1.06
Associations between antibiotic exposure during pregnancy, birth weight and aberrant methylation at imprinted genes among offspring. Int J Obes (Lond) (2013) 1.05
Plasma transforming growth factor-beta 1 reflects disease status in patients with lung cancer after radiotherapy: a possible tumor marker. Lung Cancer (1996) 1.04
Normal tissue radiobiology: from the laboratory to the clinic. Int J Radiat Oncol Biol Phys (2001) 1.04
Morphologic and histochemical analysis of hepatocytes transplanted into syngeneic hosts. Am J Pathol (1980) 1.03
Can we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction? J Clin Oncol (2001) 1.02
Transforming growth factor-beta 1 and mannose 6-phosphate/insulin-like growth factor-II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the rat. Hepatology (1994) 1.02
Disruption of ligand binding to the insulin-like growth factor II/mannose 6-phosphate receptor by cancer-associated missense mutations. J Biol Chem (1999) 1.01
The relevance of transforming growth factor beta 1 in pulmonary injury after radiation therapy. Lung Cancer (1998) 1.01
Relating radiation-induced regional lung injury to changes in pulmonary function tests. Int J Radiat Oncol Biol Phys (2001) 1.01
Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation. J Clin Oncol (2001) 1.00
Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma. Ann Surg (1995) 1.00
Effect of verapamil on malignant tissue blood flow in SMT-2A tumor-bearing rats. Cancer Res (1982) 0.99
Imprinted M6p/Igf2 receptor is mutated in rat liver tumors. Oncogene (1998) 0.99
Microwave power absorption differences between normal and malignant tissue. Int J Radiat Oncol Biol Phys (1980) 0.98
Imprint status of M6P/IGF2R and IGF2 in chickens. Dev Genes Evol (2001) 0.98
Glycosylasparaginase activity requires the alpha-carboxyl group, but not the alpha-amino group, on N(4)-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-L-asparagine. Arch Biochem Biophys (2001) 0.97
Repair of radiation damage in noncycling parenchymal hepatocytes. Br J Radiol (1982) 0.96
Blood flow to primary tumors and lymph node metastases in SMT-2A tumor-bearing rats following intravenous flunarizine. Cancer Res (1984) 0.96
Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol. Cancer Res (1995) 0.96
Comparative fos immunoreactivity in the brain after forebrain, brainstem, or combined seizures induced by electroshock, pentylenetetrazol, focally induced and audiogenic seizures in rats. Neuroscience (2004) 0.96
The effectiveness of immobilization during prostate irradiation. Int J Radiat Oncol Biol Phys (1995) 0.95
Establishment of two rat hepatoma cell strains produced by a carcinogen initiation, phenobarbital promotion protocol. In Vitro (1983) 0.93
Effects of partial hepatectomy on transplanted hepatocytes. Cancer Res (1982) 0.93
73.6 Gy and beyond: hyperfractionated, accelerated radiotherapy for non-small-cell lung cancer. J Clin Oncol (2001) 0.93
Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers. Cancer Res (1999) 0.92
Circulating thrombomodulin during radiation therapy of lung cancer. Radiat Oncol Investig (1999) 0.91
Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival. Ann Surg Oncol (2001) 0.90
Response of hepatocytes transplanted into syngeneic hosts and heterotransplanted into athymic nude mice to peroxisome proliferators. Cancer Res (1984) 0.90
Effects of EGF and calcium on adult parenchymal hepatocyte proliferation. J Cell Physiol (1987) 0.90
Imprinting of PEG3, the human homologue of a mouse gene involved in nurturing behavior. Genomics (2001) 0.90
Proton NMR and optical spectroscopic studies on the DNA triplex formed by d-A-(G-A)7-G and d-C-(T-C)7-T. J Biomol Struct Dyn (1991) 0.89
Exclusion of maternal uniparental disomy of chromosome 14 in patients referred for Prader-Willi syndrome using a multiplex methylation polymerase chain reaction assay. J Med Genet (2003) 0.88
Imprinted genes as potential genetic and epigenetic toxicologic targets. Environ Health Perspect (2000) 0.88
Mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) variants in American and Japanese populations. Hum Mutat (2001) 0.86
Short communication: normal tissue injury after cancer therapy is a local response exacerbated by an endocrine effect of TGF beta. Br J Radiol (1995) 0.86
Polymorphisms, genomic imprinting and cancer susceptibility. Mutat Res (1999) 0.86
Human hepatocyte-mediated mutagenesis and DNA repair activity. Carcinogenesis (1983) 0.86
The influence of in situ repair systems on survival of several irradiated parenchymal cell types. Br J Cancer Suppl (1984) 0.85
Carcinoma of the uterine cervix: a 3D - CT analysis of dose to the internal, external and common iliac nodes in tandem and ovoid applications. Radiother Oncol (2000) 0.84
Intracolonic WR 2721 protection of the rat colon from acute radiation injury. Gastroenterology (1986) 0.84
The tetratricopeptide repeat containing Tg737 gene is a liver neoplasia tumor suppressor gene. Oncogene (1997) 0.84